+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cerebrospinal Fluid (CSF) Management Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804655

Global Cerebrospinal Fluid (CSF) Management Devices Market to Reach $1.9 Billion by 2030

The global market for Cerebrospinal Fluid (CSF) Management Devices estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. Shunts, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the External Drainage Systems segment is readjusted to a revised 2.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $423.6 Million, While China is Forecast to Grow at 3.5% CAGR

The Cerebrospinal Fluid (CSF) Management Devices market in the U.S. is estimated at US$423.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$345 Million by the year 2030 trailing a CAGR of 3.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 3.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Select Competitors (Total 43 Featured) -

  • Argi Grup
  • B. Braun Melsungen AG
  • Delta Surgical Ltd.
  • Dispomedica GmbH
  • G. Surgiwear Ltd.
  • Integra LifeSciences Holdings Corporation
  • Medtronic PLC
  • Moller Medical GmbH
  • Natus Medical, Inc.
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Wellong Instruments Co., Ltd.


What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cerebrospinal Fluid (CSF) Management Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Shunts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Shunts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Shunts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for External Drainage Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for External Drainage Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for External Drainage Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Geriatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Geriatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Geriatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Cerebrospinal Fluid (CSF) Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: USA Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: USA 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: USA 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Canada 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Canada 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
JAPAN
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Japan 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Japan 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
CHINA
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: China Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: China 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: China 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
EUROPE
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Europe 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
FRANCE
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 53: France Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: France Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: France 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: France 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
GERMANY
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 59: Germany Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: Germany 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: Germany 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: Italy 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Italy 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 71: UK Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: UK Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: UK 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: UK 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 77: Rest of Europe Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: Rest of Europe Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: Rest of Europe 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: Rest of Europe 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Cerebrospinal Fluid (CSF) Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Asia-Pacific Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: Asia-Pacific 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Asia-Pacific 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 89: Rest of World Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Rest of World Historic Review for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Shunts and External Drainage Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Rest of World 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by Product Type - Percentage Breakdown of Value Sales for Shunts and External Drainage Systems for the Years 2014, 2023 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World Historic Review for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Pediatric, Adult and Geriatric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of World 16-Year Perspective for Cerebrospinal Fluid (CSF) Management Devices by End-Use - Percentage Breakdown of Value Sales for Pediatric, Adult and Geriatric for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Argi Grup
  • B. Braun Melsungen AG
  • Delta Surgical Ltd.
  • Dispomedica GmbH
  • G. Surgiwear Ltd.
  • Integra LifeSciences Holdings Corporation
  • Medtronic PLC
  • Moller Medical GmbH
  • Natus Medical, Inc.
  • Sophysa SA
  • Spiegelberg GmbH & Co. KG
  • Wellong Instruments Co., Ltd.

Table Information